Welcome to our dedicated page for Omnicell Com news (Ticker: OMCL), a resource for investors and traders seeking the latest updates and insights on Omnicell Com stock.
Omnicell, Inc. (NASDAQ: OMCL) is a healthcare technology company focused on intelligent medication management, and the OMCL news page on Stock Titan aggregates company-specific updates that matter to investors and healthcare observers. Omnicell describes itself as a leader in transforming the pharmacy and nursing care delivery model, with solutions that combine automation, AI-enabled intelligence, and expert services to support clinical, operational, and financial outcomes across all settings of care.
News related to Omnicell often centers on financial results, product innovation, and strategic developments. The company regularly issues earnings releases and guidance updates, discussing performance across categories such as connected devices, technical services, SaaS and Expert Services, and consumables. Press releases also cover events like conference presentations, investor Q&A sessions, and participation in industry meetings, providing context on how management communicates its strategy and outlook.
Product and technology announcements are another key theme in OMCL news. Examples include the launch of Omnicell Titan XT, an enterprise automated dispensing system powered by the OmniSphere cloud platform, and updates on OmniSphere certifications and capabilities. Omnicell also highlights initiatives such as specialty pharmacy services, URAC Health Care Management Certification, and innovation-focused events like Omnicell Illuminate and the IV TRUST Summit, which showcase developments in robotics, smart devices, software workflows, and data and analytics.
By following OMCL news, readers can monitor how Omnicell advances its vision of autonomous medication management, how it positions its solutions for health systems, retail and specialty pharmacies, and how management addresses risks and opportunities in a regulated healthcare environment. The Stock Titan news feed helps users track these announcements in one place for ongoing reference.
Omnicell, a leader in medication management solutions, has announced the appointment of Christine Mellon as Executive Vice President and Chief People Officer. With over 25 years of experience in human resources, Mellon's role will be crucial as Omnicell evolves towards its vision of Autonomous Pharmacy. She aims to enhance talent management, employee culture, diversity, and inclusion within the organization. Previously, Mellon served as CHRO at CSG and held key HR positions at Oracle and other firms. Omnicell has been transforming pharmacy care since 1992, providing solutions to improve medication management outcomes.
Omnicell, a leader in medication management solutions, has announced its participation in two upcoming investor conferences. Peter Kuipers, CFO, will present at the BTIG Virtual MedTech Conference on February 19 at 11:30 am ET. Additionally, Randall Lipps, CEO, and Peter Kuipers will present at the Barclays Global Healthcare Conference on March 9 at 1:50 pm ET. Archived webcasts will be available on the Omnicell website. Omnicell has over 7,000 facilities using its solutions to improve operational efficiency and patient safety.
Omnicell, a provider of medication management solutions, reported its Q4 and full-year 2020 results. Q4 revenues reached $249.2 million, slightly up from Q4 2019, while total revenues for 2020 were $892.2 million, down $4.8 million year-over-year. Q4 GAAP net income declined to $16.4 million from $22.1 million, with annual GAAP net income at $32.2 million, down from $61.3 million in 2019. However, product bookings soared by 23% to $1.002 billion for the year, and backlog increased by 57% to $924 million. For 2021, revenue guidance is set between $1.085 billion and $1.105 billion.
Omnicell (Nasdaq:OMCL) has secured a 10-year sole source agreement renewal with WVU Medicine to enhance pharmacy supply chain management using Omnicell One™, its cloud-based medication inventory platform. This partnership aims to improve pharmacy operations by reducing medication waste and enhancing productivity through advanced analytics. With an estimated $800 million wasted due to expired medications, the new agreement promises to address these inefficiencies. Nearly half of the Top 300 U.S. health systems are collaborating with Omnicell, advancing towards the Autonomous Pharmacy model for better medication management.
Omnicell, a leader in medication management solutions, reported strong preliminary financial results for FY 2020, exceeding its pre-pandemic guidance. The company anticipates product bookings of around $1.00 billion, total revenues between $890 million and $892 million, and non-GAAP earnings per share of $2.46 to $2.51. For 2021, Omnicell projects total revenues between $1.085 billion and $1.105 billion, alongside a significant increase in non-GAAP EBITDA, indicating robust growth prospects amid the ongoing pandemic.
Omnicell, Inc. (Nasdaq:OMCL) reported robust demand for its new CareScheduler digital solution, designed for pharmacies to manage COVID-19 vaccine administration efficiently. Developed by EnlivenHealth™, this Software as a Service (SaaS) automates vaccine processes, enhancing patient safety and operational efficiency. Over 50 major pharmacy chains are in discussions to adopt CareScheduler, with nearly 1,000 stores already signed up. The solution is expected to help pharmacies manage increasing patient volumes while improving growth and profitability amidst the pandemic.
Omnicell, Inc. (Nasdaq: OMCL) has announced a new partnership with Guy's and St Thomas' NHS Foundation Trust to enhance inventory optimization and intelligence services. This follows a £10.5 million investment aimed at expanding automation systems across six hospitals in South East London. The partnership will also create a technology-enabled intelligence center to provide advanced analytics for supply and medication management. By utilizing AI tools, the initiative aims to improve efficiency, reduce errors, and enhance patient safety.
Omnicell, a leader in medication management solutions, announces an expansion of its partnership with Owensboro Health, implementing the Central Pharmacy Dispensing Service. This innovative platform includes the Omnicell XR2 robotic dispensing system aimed at enhancing inventory control and minimizing medication errors. Owensboro Health aims to streamline their medication supply chain, improving patient care outcomes. The Central Pharmacy Dispensing Service is a key step towards achieving an Autonomous Pharmacy, which focuses on automated medication management.
Omnicell (Nasdaq:OMCL) announced its participation in upcoming investor conferences. Randall Lipps, Chairman and CEO, and Peter Kuipers, CFO, will present at the J.P. Morgan 39th Annual Healthcare Conference on January 13, 2021, at 2:00 PM ET. Live and archived webcasts of the presentation will be accessible on the Omnicell website. Since its inception in 1992, Omnicell has focused on transforming pharmacy care delivery, with over 7,000 facilities worldwide utilizing its solutions to enhance efficiency and patient safety.
Summary not available.